source
- Biotech firms must adopt global regulatory strategies to commercialize drugs independentlyBiotech developers are increasingly able to fund the pursuit of regulatory approval and commercial launch on their own, rather than selling their assets early. This new option is driven by a reboun…
- Formation Bio raises $600 million fund to expand AI-driven drug licensing and testing modelFormation Bio, an AI-focused biotech that builds value by acquiring external drug assets, developing them and then transferring them to partners, announced a new financing round. The company secur…